Operating Metrics 營運指標
McKesson Corporation (MCK) Operating Metrics 營運指標
McKesson Corporation MCK 最近 8 季公司營運 KPI、指標定義、跨期趨勢與官方來源。
資料截至：2026-06-30
最新營運指標
- North American Pharmaceutical Revenue
- $340,696M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
- Oncology & Multispecialty Revenue
- $51,987M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
- Prescription Technology Solutions Revenue
- $5,937M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
- Medical-Surgical Solutions Revenue
- $11,625M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
- North American Pharmaceutical Adjusted Operating Profit
- $3,597M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
- Oncology & Multispecialty Adjusted Operating Profit
- $1,553M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
- Prescription Technology Solutions Adjusted Operating Profit
- $1,163M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
- Medical-Surgical Solutions Adjusted Operating Profit
- $980M · 2026-06-30 來源：McKesson Corporation、McKesson Corporation、McKesson Corporation、McKesson Corporation
季度趨勢
| 指標 | Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|---|
| North American Pharmaceutical Revenue | $86,773M | $79,120M | $88,322M | $86,481M | $82,729M | $76,943M | $81,198M | $80,018M |
| Oncology & Multispecialty Revenue | $14,222M | $12,711M | $13,010M | $12,044M | $10,658M | $9,431M | $9,493M | $9,157M |
| Prescription Technology Solutions Revenue | $1,566M | $1,495M | $1,500M | $1,376M | $1,434M | $1,339M | $1,371M | $1,265M |
| Medical-Surgical Solutions Revenue | $2,819M | $2,868M | $2,991M | $2,947M | $2,701M | $2,853M | $2,949M | $2,946M |
| North American Pharmaceutical Adjusted Operating Profit | $894M | $980M | $872M | $851M | $749M | $885M | $822M | $754M |
| Oncology & Multispecialty Adjusted Operating Profit | $405M | $385M | $366M | $397M | $287M | $252M | $233M | $232M |
| Prescription Technology Solutions Adjusted Operating Profit | $303M | $322M | $277M | $261M | $269M | $285M | $235M | $218M |
| Medical-Surgical Solutions Adjusted Operating Profit | $195M | $271M | $265M | $249M | $244M | $285M | $294M | $243M |
資料來源
- McKesson Fiscal 2027 First Quarter Results · McKesson Corporation · 2026-08-05
- McKesson Fiscal 2026 Fourth Quarter Results · McKesson Corporation · 2026-05-07
- McKesson Fiscal 2026 Third Quarter Results · McKesson Corporation · 2026-02-04
- McKesson Fiscal 2026 Second Quarter Results · McKesson Corporation · 2025-11-05